Dr. Ross Camidge explains exactly what an ALK-positive lung cancer is. ALK is an important biomarker that can impact lung cancer treatment options. Talk to your doctor about comprehensive biomarker testing. Visit Lung.org/alk for more information.
Support for this educational program provided by Amgen, AstraZeneca, Blueprint Medicines, Bristol Myers Squibb, Genentech, Lilly Oncology, Merck, Novartis and Pfizer.
